Short Communication - (2025) Volume 8, Issue 4
Received: 08-Aug-2025, Manuscript No. jbr-26-182901;
Editor assigned: 11-Aug-2025, Pre QC No. P-182901;
Reviewed: 25-Aug-2025, QC No. Q-182901;
Revised: 29-Aug-2025, Manuscript No. r-182901;
Published:
30-Aug-2025
, DOI: 10.38421/2684-4583.2025.8.328
Citation: Mendez, Carlos. ”Brain Energy Metabolism: Key to Neurological Health and Disease.” J Brain Res 08 (2025):328.
Copyright: © 2025 Mendez C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Brain energy metabolism plays a crucial and multifaceted role in the development and progression of a wide array of neurological disorders. Understanding these intricate metabolic pathways is paramount for developing effective therapeutic interventions. Disruptions in the delicate balance of glucose and oxygen supply to the brain, coupled with impaired mitochondrial function and altered adenosine triphosphate (ATP) production, are increasingly recognized as significant contributors to neuronal damage and eventual loss observed in conditions such as Alzheimer's disease, Parkinson's disease, and stroke. Researchers are actively exploring the potential of targeting these specific metabolic pathways for novel therapeutic strategies [1].
Mitochondrial dysfunction has emerged as a common pathogenic mechanism underlying various neurodegenerative diseases. The decline in mitochondrial respiration efficiency and the consequent increase in oxidative stress lead to critical energy deficits within neurons, ultimately triggering apoptotic pathways. The ongoing research in this area is focused on identifying and developing therapeutic strategies aimed at restoring mitochondrial integrity and improving cellular energy homeostasis, offering hope for treating these debilitating conditions [2].
Altered glucose metabolism has been directly implicated in the cognitive decline associated with Alzheimer's disease. Studies have demonstrated a strong correlation between reduced glucose uptake and utilization in specific brain regions and the pathological hallmarks of the disease, namely amyloid-beta plaque accumulation and tau pathology. These findings suggest that interventions designed to enhance glucose metabolism could prove beneficial for early diagnosis and intervention in Alzheimer's disease [3].
Astrocytes, the primary glial cells in the brain, play a critical role in maintaining neuronal energy supply, especially under conditions of metabolic stress. They are responsible for providing essential metabolic support, such as lactate, to neurons, thereby sustaining their energy needs and ensuring proper synaptic function. Dysregulation of this vital astrocytic support system has been linked to the pathogenesis of various neurological disorders, highlighting their importance in brain health [4].
The ketogenic diet, which shifts the brain's primary energy source from glucose to ketone bodies, has shown promising neuroprotective effects in preclinical models of epilepsy and traumatic brain injury. This metabolic shift can effectively reduce neuronal hyperexcitability and mitigate neuroinflammation. The exploration of dietary interventions like the ketogenic diet is gaining traction for neurological conditions characterized by impaired glucose metabolism [5].
Following a stroke, the brain undergoes significant hypoxia-induced changes in its energy metabolism, profoundly impacting neuronal survival and the capacity for functional recovery. Understanding the altered glucose and oxygen utilization patterns after ischemic events is crucial for identifying therapeutic targets that can optimize energy availability during the critical post-stroke period, thereby improving patient outcomes [6].
Aging is accompanied by a decline in brain energy metabolism, contributing to age-related cognitive decline and increasing susceptibility to neurodegenerative diseases. This decline is characterized by reduced efficiency in glucose utilization and compromised mitochondrial function, making neurons more vulnerable. Maintaining metabolic health throughout life is therefore considered crucial for preserving cognitive function and promoting healthy brain aging [7].
Targeting NAD+ metabolism presents a promising therapeutic avenue for neurodegenerative diseases. NAD+ levels naturally decline with age and disease, leading to impaired mitochondrial function and increased neuroinflammation, both of which contribute to neuronal damage. Strategies aimed at boosting NAD+ levels are being investigated for their potential to restore cellular energy and slow disease progression [8].
Impaired lipid metabolism is intricately linked with neuroinflammation in Parkinson's disease. Dysregulation in fatty acid oxidation and cholesterol homeostasis can exacerbate alpha-synuclein aggregation and accelerate the loss of dopaminergic neurons. Modulating these lipid pathways offers potential new therapeutic strategies for managing Parkinson's disease [9].
Peroxisome proliferator-activated receptors (PPARs) are critical regulators of brain energy metabolism and are highly relevant to neurological disorders. Agonists targeting PPARs have demonstrated the ability to influence glucose uptake, enhance mitochondrial function, and reduce neuroinflammation, presenting a viable therapeutic strategy for conditions such as stroke and Alzheimer's disease [10].
The intricate interplay between brain energy metabolism and the pathogenesis of neurological disorders is a subject of intense scientific scrutiny. This article delves into how fundamental metabolic processes, such as glucose and oxygen supply, mitochondrial activity, and ATP generation, are disrupted in conditions like Alzheimer's disease, Parkinson's disease, and stroke, leading to neuronal damage and loss. The potential for therapeutic interventions targeting these metabolic pathways is a key focus [1].
A central theme in neurodegenerative diseases is mitochondrial dysfunction, which compromises the energy production capacity of neurons. Impaired mitochondrial respiration and an increase in oxidative stress contribute to energy deficits and neuronal cell death. The ongoing development of therapeutic strategies aims to restore mitochondrial function and improve cellular energy balance, offering new hope for patients [2].
The impact of impaired glucose metabolism on cognitive function in Alzheimer's disease is a critical area of research. Studies have established a link between reduced glucose uptake in specific brain regions and the accumulation of amyloid-beta plaques and tau tangles, the characteristic pathologies of Alzheimer's. This suggests that enhancing glucose metabolism could be a valuable approach for early intervention [3].
Astrocytes serve as essential regulators of neuronal energy supply, particularly under stressful conditions. They provide metabolic substrates, such as lactate, to neurons, thereby supporting neuronal function and synaptic activity. Any disruption in this astrocytic support network can have detrimental effects on neuronal health and contribute to neurological disorders [4].
In certain neurological conditions, such as epilepsy and traumatic brain injury, the ketogenic diet has demonstrated neuroprotective capabilities. By facilitating a shift to ketone bodies as an alternative energy source, this diet can reduce neuronal hyperexcitability and inflammation. Its potential as a therapeutic intervention for disorders involving impaired glucose metabolism is being actively investigated [5].
Following a stroke, the brain experiences a state of hypoxia that significantly alters energy metabolism, affecting neuronal survival and the potential for recovery. Understanding these hypoxia-induced metabolic changes is crucial for identifying therapeutic targets that can optimize energy availability in the post-stroke period and promote better functional outcomes [6].
Aging is associated with a progressive decline in brain energy metabolism, contributing to age-related cognitive impairment and an increased risk of neurodegenerative diseases. Reduced efficiency in glucose utilization and mitochondrial function renders aging brains more susceptible to damage. Maintaining metabolic health is considered a vital factor for healthy brain aging [7].
The therapeutic potential of targeting NAD+ metabolism in neurodegenerative diseases is being explored. A decrease in NAD+ levels, often seen with aging and disease, impairs mitochondrial function and promotes inflammation, both of which drive neuronal damage. Strategies to boost NAD+ are being investigated for their capacity to restore cellular energy and mitigate disease progression [8].
Neuroinflammation in Parkinson's disease is closely linked to dysfunctions in lipid metabolism. Impaired fatty acid oxidation and altered cholesterol homeostasis can contribute to the aggregation of alpha-synuclein and the subsequent loss of dopaminergic neurons. Therapeutic interventions targeting lipid pathways may offer new avenues for treating Parkinson's disease [9].
Peroxisome proliferator-activated receptors (PPARs) play a significant role in regulating brain energy metabolism and are implicated in various neurological disorders. The use of PPAR agonists is being investigated for their ability to improve glucose uptake, enhance mitochondrial function, and reduce neuroinflammation, presenting a promising therapeutic strategy for conditions like stroke and Alzheimer's disease [10].
Neurological disorders are closely linked to disruptions in brain energy metabolism. Issues with glucose and oxygen supply, mitochondrial function, and ATP production contribute to neuronal damage in conditions like Alzheimer's, Parkinson's, and stroke, suggesting therapeutic targets within these metabolic pathways. Mitochondrial dysfunction, characterized by impaired respiration and oxidative stress, is a common factor in neurodegeneration, leading to energy deficits and cell death. Impaired glucose metabolism is particularly implicated in Alzheimer's disease, correlating with key pathological features and suggesting enhancement as an intervention strategy. Astrocytes play a vital role in supplying neurons with energy substrates, and their dysfunction can contribute to neurological diseases. The ketogenic diet offers an alternative energy source and has shown neuroprotective effects in models of epilepsy and brain injury. Post-stroke hypoxia significantly alters brain energy metabolism, impacting recovery. Aging also leads to metabolic decline in the brain, increasing vulnerability. Targeting NAD+ metabolism shows promise for neurodegeneration by improving mitochondrial function and reducing inflammation. Lipid metabolism dysregulation is linked to neuroinflammation in Parkinson's disease, with modulation offering therapeutic potential. Finally, PPARs are key regulators of brain energy metabolism, and their activation is being explored as a therapeutic strategy for neurological conditions.
None
None
Journal of Brain Research received 2 citations as per Google Scholar report
